Top compounds associated with response to ABCD2


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.13 0.0007
mRNA lenvatinib CTRPv2 pan-cancer AAC 0.13 0.0008
mRNA GSK690693 GDSC1000 pan-cancer AAC -0.11 0.0009
mRNA ciclosporin CTRPv2 pan-cancer AAC 0.13 0.0009
mRNA AZ628 GDSC1000 pan-cancer AAC -0.17 0.0009
mRNA Pyrimethamine GDSC1000 pan-cancer AAC -0.17 0.001
mRNA ML311 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA masitinib GDSC1000 pan-cancer AAC -0.11 0.001
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.092 0.001
Download CSV